CLINICAL SIGNIFICANSE OF HUMAN RECOMBINANT TSH IN THE SURVEILLANCE AND TREATMENT OF PATIENT WITH THYROID CARCINOME
Abstract Recombinant human TSH (rhTSH) is an effective and safe alternative to thyroid hormone withdrawal during the post-surgical follow up of papillary and follicular thyroid cancer. Its clinical efficiency for the detection of persistent and recurrent disease is similar to that of thyroid hormone withdrawal. The main purpose for its use is to avoid hypothyroidism.